Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Wednesday, March 2, 2016

Gut Microbiota & MEBO Metabolomic Research Study

An interesting and easy to understand explanation of the role of gut microbiota, how the foods we eat affect our gut microflora no matter what part of the earth we live in. Giulia Enders talks about studies linking gut microflora to obesity, auto-immune diseases, and the long-term consequences of the use of antibiotics on gut microbiota compasition and diseases.

Unfortunately, no mention was made about gut microbiota and malodor conditions, most probably because there has not been research on this. The new groundbreaking MEBO Microbolomic Research Study is all about understanding the sufferer' gut microflora in relation to odor and treatment.

Approved Exploratory Research Study

Metabolomic Profiling of Urine Samples
for the Identification of Novel Biomarkers and Mechanisms
in the Diagnosis and Management of Malodor Associated with
Metabolic Inefficiencies
(ID: 201505010014MEBO/ NCT02683876)

Information on this research carried out by U.S. Principal Investigator Irene Gabashvili, PhD, MEBO Scientific Director, and collaborating registered Principal Investigator, David Whishart, PhD, of the Metabolomics Innovation Centre (MIC) of the University of Alberta, Edmonton, Canada, can be found on the Clinical Trials website at,

See post in this blog, Microbes and us, dated February 17, 2010

View more presentations from Aurametrix.

María de la Torre
Founder and Executive Director

A Public Charity
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)

Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner

A EURORDIS and NORD Member Organization


Post a Comment